These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 31836686

  • 21. 18F-PSMA-1007 PET/CT at 60 and 120 minutes in patients with prostate cancer: biodistribution, tumour detection and activity kinetics.
    Rahbar K, Afshar-Oromieh A, Bögemann M, Wagner S, Schäfers M, Stegger L, Weckesser M.
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1329-1334. PubMed ID: 29541812
    [Abstract] [Full Text] [Related]

  • 22. Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
    Jansen BHE, Cysouw MCF, Vis AN, van Moorselaar RJA, Voortman J, Bodar YJL, Schober PR, Hendrikse NH, Hoekstra OS, Boellaard R, Oprea-Lager DE.
    J Nucl Med; 2020 Sep; 61(9):1320-1325. PubMed ID: 31924729
    [Abstract] [Full Text] [Related]

  • 23. Detection efficacy of 18F-rhPSMA-7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatment.
    Rauscher I, Karimzadeh A, Schiller K, Horn T, D'Alessandria C, Franz C, Wörther H, Nguyen N, Combs SE, Weber WA, Eiber M.
    J Nucl Med; 2021 Mar 12; 62(12):1719-26. PubMed ID: 33712531
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Validation of 18F-rhPSMA-7 and 18F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate Cancer.
    Kroenke M, Schweiger L, Horn T, Haller B, Schwamborn K, Wurzer A, Maurer T, Wester HJ, Eiber M, Rauscher I.
    J Nucl Med; 2022 Dec 12; 63(12):1809-1814. PubMed ID: 35393348
    [Abstract] [Full Text] [Related]

  • 26. 18F-DCFPyL PET/CT in the Detection of Prostate Cancer at 60 and 120 Minutes: Detection Rate, Image Quality, Activity Kinetics, and Biodistribution.
    Wondergem M, van der Zant FM, Knol RJJ, Lazarenko SV, Pruim J, de Jong IJ.
    J Nucl Med; 2017 Nov 12; 58(11):1797-1804. PubMed ID: 28450569
    [Abstract] [Full Text] [Related]

  • 27. Preclinical comparison of four [18F, natGa]rhPSMA-7 isomers: influence of the stereoconfiguration on pharmacokinetics.
    Wurzer A, Parzinger M, Konrad M, Beck R, Günther T, Felber V, Färber S, Di Carlo D, Wester HJ.
    EJNMMI Res; 2020 Dec 07; 10(1):149. PubMed ID: 33284394
    [Abstract] [Full Text] [Related]

  • 28. In Vitro and In Vivo Characterization of an 18F-AlF-Labeled PSMA Ligand for Imaging of PSMA-Expressing Xenografts.
    Lütje S, Franssen GM, Herrmann K, Boerman OC, Rijpkema M, Gotthardt M, Heskamp S.
    J Nucl Med; 2019 Jul 07; 60(7):1017-1022. PubMed ID: 30655329
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Automated synthesis of [18F]Ga-rhPSMA-7/ -7.3: results, quality control and experience from more than 200 routine productions.
    Wurzer A, Di Carlo D, Herz M, Richter A, Robu S, Schirrmacher R, Mascarin A, Weber W, Eiber M, Schwaiger M, Wester HJ.
    EJNMMI Radiopharm Chem; 2021 Jan 23; 6(1):4. PubMed ID: 33484364
    [Abstract] [Full Text] [Related]

  • 32. Quantitative and Qualitative Assessment of Urinary Activity of 18F-Flotufolastat-PET/CT in Patients with Prostate Cancer: a Post Hoc Analysis of the LIGHTHOUSE and SPOTLIGHT Studies.
    Kuo PH, Hermsen R, Penny R, Postema EJ.
    Mol Imaging Biol; 2024 Feb 23; 26(1):53-60. PubMed ID: 37932609
    [Abstract] [Full Text] [Related]

  • 33. Intraindividual Comparison of 18F-PSMA-1007 and 18F-DCFPyL PET/CT in the Prospective Evaluation of Patients with Newly Diagnosed Prostate Carcinoma: A Pilot Study.
    Giesel FL, Will L, Lawal I, Lengana T, Kratochwil C, Vorster M, Neels O, Reyneke F, Haberkon U, Kopka K, Sathekge M.
    J Nucl Med; 2018 Jul 23; 59(7):1076-1080. PubMed ID: 29269569
    [Abstract] [Full Text] [Related]

  • 34. Biodistribution and radiation dosimetry of [18F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancer.
    Hohberg M, Kobe C, Krapf P, Täger P, Hammes J, Dietlein F, Zlatopolskiy BD, Endepols H, Wild M, Neubauer S, Heidenreich A, Neumaier B, Drzezga A, Dietlein M.
    EJNMMI Res; 2019 Jul 25; 9(1):66. PubMed ID: 31346821
    [Abstract] [Full Text] [Related]

  • 35. Temporary Reactive Response of Axillary Lymph Nodes to COVID-19 Vaccination on 18F-rhPSMA-7.3 PET/CT in Patients with Prostate Cancer.
    Notohamiprodjo S, Eiber M, Lohrmann C, Weber WA.
    J Nucl Med; 2022 Nov 25; 63(11):1673-1676. PubMed ID: 35241484
    [Abstract] [Full Text] [Related]

  • 36. Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies.
    Wurzer A, De Rose F, Fischer S, Schwaiger M, Weber W, Nekolla S, Wester HJ, Eiber M, D'Alessandria C.
    EJNMMI Radiopharm Chem; 2024 Feb 26; 9(1):18. PubMed ID: 38407630
    [Abstract] [Full Text] [Related]

  • 37. Impact of 18F-PSMA-1007 Uptake in Prostate Cancer Using Different Peptide Concentrations: Preclinical PET/CT Study on Mice.
    Soeda F, Watabe T, Naka S, Liu Y, Horitsugi G, Neels OC, Kopka K, Tatsumi M, Shimosegawa E, Giesel FL, Hatazawa J.
    J Nucl Med; 2019 Nov 26; 60(11):1594-1599. PubMed ID: 30902876
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.
    Rowe SP, Macura KJ, Mena E, Blackford AL, Nadal R, Antonarakis ES, Eisenberger M, Carducci M, Fan H, Dannals RF, Chen Y, Mease RC, Szabo Z, Pomper MG, Cho SY.
    Mol Imaging Biol; 2016 Jun 26; 18(3):411-9. PubMed ID: 27080322
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.